Chinese academic community speaks out on He Jiankui again: Consensus statement on the challenges and responses of science and technology ethics governance

Xiaomei Zhai
{"title":"Chinese academic community speaks out on He Jiankui again: Consensus statement on the challenges and responses of science and technology ethics governance","authors":"Xiaomei Zhai","doi":"10.1002/hcs2.41","DOIUrl":null,"url":null,"abstract":"<p>At the end of 2019, He Jiankui was sentenced to 3 years in prison for “illegal medical practices”. The Ministry of Science and Technology and the National Health Commission of P.R. China have banned him from engaging in any work related to reproductive science such as in vitro fertilization, and prohibited him from conducting further research in genetic editing.</p><p>On November 24, 2022, He Jiankui announced on his personal Weibo account for the establishment of the He Jiankui Laboratory in Beijing's Daxing district, and extensively promoted his rare disease research plan through social media and the press, calling it a “new starting point, a new journey”.</p><p>On February 13, 2023, Nature News reported that He Jiankui participated in an online exchange event organized by the University of Kent in the United Kingdom, focusing on life ethics regulation. Many scholars were disappointed with his speech, which they believed was “a publicity stunt” that only “left the impression of a salesperson” [<span>1</span>]. Similar disappointment and criticism were expressed by the Chinese academic community toward He Jiankui's speech.</p><p>On March 2, 2023, a Conference on “Challenges and Responses to Ethical Governance of Science and Technology” was held in Beijing. The Conference was organized jointly by Center for Ethics and Morality, People's University of China, Beijing Institute of Stem Cell and Regenerative Medicine, and Center for Bioethics, Chinese Academy of Medical Sciences/Peking Union Medical College. Over 200 scholars from all over the country attended the conference.</p><p><b>Xiaomei Zhai</b>: Conceptualization (lead); resources (lead); writing—original draft (lead).</p><p>The author declares no conflict of interest.</p><p>The author has nothing to report. No patient was involved in the present study.</p><p>Not applicable.</p>","PeriodicalId":100601,"journal":{"name":"Health Care Science","volume":"2 2","pages":"79-81"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hcs2.41","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Care Science","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hcs2.41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

At the end of 2019, He Jiankui was sentenced to 3 years in prison for “illegal medical practices”. The Ministry of Science and Technology and the National Health Commission of P.R. China have banned him from engaging in any work related to reproductive science such as in vitro fertilization, and prohibited him from conducting further research in genetic editing.

On November 24, 2022, He Jiankui announced on his personal Weibo account for the establishment of the He Jiankui Laboratory in Beijing's Daxing district, and extensively promoted his rare disease research plan through social media and the press, calling it a “new starting point, a new journey”.

On February 13, 2023, Nature News reported that He Jiankui participated in an online exchange event organized by the University of Kent in the United Kingdom, focusing on life ethics regulation. Many scholars were disappointed with his speech, which they believed was “a publicity stunt” that only “left the impression of a salesperson” [1]. Similar disappointment and criticism were expressed by the Chinese academic community toward He Jiankui's speech.

On March 2, 2023, a Conference on “Challenges and Responses to Ethical Governance of Science and Technology” was held in Beijing. The Conference was organized jointly by Center for Ethics and Morality, People's University of China, Beijing Institute of Stem Cell and Regenerative Medicine, and Center for Bioethics, Chinese Academy of Medical Sciences/Peking Union Medical College. Over 200 scholars from all over the country attended the conference.

Xiaomei Zhai: Conceptualization (lead); resources (lead); writing—original draft (lead).

The author declares no conflict of interest.

The author has nothing to report. No patient was involved in the present study.

Not applicable.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中国学界再发声贺建奎:关于科技伦理治理挑战与应对的共识声明
2019年底,贺建奎因“非法行医”被判处有期徒刑3年。中国科学技术部和国家卫生健康委员会禁止他从事任何与生殖科学有关的工作,如体外受精,并禁止他在基因编辑方面进行进一步研究。2022年11月24日,贺建奎在其个人微博账号上宣布在北京大兴区成立贺建奎实验室,并通过社交媒体和媒体广泛宣传其罕见病研究计划,称其为“新起点,新征程”。2023年2月13日,《自然新闻》报道称,贺建奎参加了英国肯特大学组织的一场在线交流活动,重点关注生命伦理规范。许多学者对他的演讲感到失望,他们认为这是“一种宣传噱头”,只“给人留下销售人员的印象”[1]。中国学术界对贺建奎的讲话也表达了类似的失望和批评。2023年3月2日,“科技伦理治理面临的挑战与对策”会议在北京召开。会议由中国人民大学伦理道德中心、北京干细胞与再生医学研究所、中国医学科学院/北京协和医学院生物伦理中心联合举办。来自全国各地的200多名学者参加了会议。翟晓梅:概念化(铅);资源(领导);写作——原始草稿。作者声明没有利益冲突。作者没有什么要报告的。本研究未涉及任何患者。不适用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.90
自引率
0.00%
发文量
0
期刊最新文献
Study protocol: A national cross-sectional study on psychology and behavior investigation of Chinese residents in 2023. Caregiving in Asia: Priority areas for research, policy, and practice to support family caregivers. Innovative public strategies in response to COVID-19: A review of practices from China. Sixty years of ethical evolution: The 2024 revision of the Declaration of Helsinki (DoH). A novel ensemble ARIMA-LSTM approach for evaluating COVID-19 cases and future outbreak preparedness.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1